Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series. Indian J Case Reports [Internet]. 2021 Nov. 26 [cited 2025 Apr. 9];7(11):469-72. Available from: https://mansapublishers.com/index.php/ijcr/article/view/3107